These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 24698732)

  • 1. Multi-marker analysis of circulating cell-free DNA toward personalized medicine for colorectal cancer.
    Mouliere F; El Messaoudi S; Pang D; Dritschilo A; Thierry AR
    Mol Oncol; 2014 Jul; 8(5):927-41. PubMed ID: 24698732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating DNA as a Strong Multimarker Prognostic Tool for Metastatic Colorectal Cancer Patient Management Care.
    El Messaoudi S; Mouliere F; Du Manoir S; Bascoul-Mollevi C; Gillet B; Nouaille M; Fiess C; Crapez E; Bibeau F; Theillet C; Mazard T; Pezet D; Mathonnet M; Ychou M; Thierry AR
    Clin Cancer Res; 2016 Jun; 22(12):3067-77. PubMed ID: 26847055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Targeted Q-PCR-Based Method for Point Mutation Testing by Analyzing Circulating DNA for Cancer Management Care.
    Thierry AR
    Methods Mol Biol; 2016; 1392():1-16. PubMed ID: 26843041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating cell-free-DNA concentration is a good biomarker for diagnosis of colorectal cancer in Mexican patients.
    Saucedo-Sariñana AM; Lugo-Escalante CR; Barros-Núñez P; Marín-Contreras ME; Pineda-Razo TD; Mariscal-Ramírez I; Gallegos-Arreola MP; Rosales-Reynoso MA
    Cell Mol Biol (Noisy-le-grand); 2022 Jun; 68(6):1-8. PubMed ID: 36227685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Cell-Free DNA from Colorectal Cancer Patients May Reveal High KRAS or BRAF Mutation Load.
    Mouliere F; El Messaoudi S; Gongora C; Guedj AS; Robert B; Del Rio M; Molina F; Lamy PJ; Lopez-Crapez E; Mathonnet M; Ychou M; Pezet D; Thierry AR
    Transl Oncol; 2013 Jun; 6(3):319-28. PubMed ID: 23730412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.
    Li M; Jia Y; Xu J; Cheng X; Xu C
    Ann Hematol; 2017 Aug; 96(8):1343-1351. PubMed ID: 28623396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating cell-free DNA mutation patterns in early and late stage colon and pancreatic cancer.
    Vietsch EE; Graham GT; McCutcheon JN; Javaid A; Giaccone G; Marshall JL; Wellstein A
    Cancer Genet; 2017 Dec; 218-219():39-50. PubMed ID: 29153095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the quantification of KRAS mutations by digital PCR and E-ice-COLD-PCR in circulating-cell-free DNA from metastatic colorectal cancer patients.
    Sefrioui D; Mauger F; Leclere L; Beaussire L; Di Fiore F; Deleuze JF; Sarafan-Vasseur N; Tost J
    Clin Chim Acta; 2017 Feb; 465():1-4. PubMed ID: 27940131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of KRAS mutation detection using circulating cell-free DNA from patients with colorectal cancer.
    Yamada T; Iwai T; Takahashi G; Kan H; Koizumi M; Matsuda A; Shinji S; Yamagishi A; Yokoyama Y; Tatsuguchi A; Kawagoe T; Kitano S; Nakayama M; Matsumoto S; Uchida E
    Cancer Sci; 2016 Jul; 107(7):936-43. PubMed ID: 27116474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of colorectal cancer-related mutations by liquid biopsy: Utility of circulating cell-free DNA and circulating tumor cells.
    Takeda K; Yamada T; Takahashi G; Iwai T; Ueda K; Kuriyama S; Koizumi M; Matsuda A; Shinji S; Ohta R; Yokoyama Y; Hotta M; Hara K; Yoshida H
    Cancer Sci; 2019 Nov; 110(11):3497-3509. PubMed ID: 31465598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The promise of liquid biopsy in colorectal cancer.
    Diaz LA
    Clin Adv Hematol Oncol; 2014 Oct; 12(10):688-9. PubMed ID: 25658893
    [No Abstract]   [Full Text] [Related]  

  • 12. High fragmentation characterizes tumour-derived circulating DNA.
    Mouliere F; Robert B; Arnau Peyrotte E; Del Rio M; Ychou M; Molina F; Gongora C; Thierry AR
    PLoS One; 2011; 6(9):e23418. PubMed ID: 21909401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial.
    Tabernero J; Lenz HJ; Siena S; Sobrero A; Falcone A; Ychou M; Humblet Y; Bouché O; Mineur L; Barone C; Adenis A; Yoshino T; Goldberg RM; Sargent DJ; Wagner A; Laurent D; Teufel M; Jeffers M; Grothey A; Van Cutsem E
    Lancet Oncol; 2015 Aug; 16(8):937-48. PubMed ID: 26184520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-invasive genotyping of metastatic colorectal cancer using circulating cell free DNA.
    Shi X; Duose DY; Mehrotra M; Harmon MA; Hu P; Wistuba II; Kopetz S; Luthra R
    Cancer Genet; 2019 Sep; 237():82-89. PubMed ID: 31447070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts.
    Thierry AR; Mouliere F; Gongora C; Ollier J; Robert B; Ychou M; Del Rio M; Molina F
    Nucleic Acids Res; 2010 Oct; 38(18):6159-75. PubMed ID: 20494973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of quantitative SEPT9 and SHOX2 methylation in plasmatic circulating cell-free DNA as auxiliary staging parameter in colorectal cancer: a prospective observational cohort study.
    Bergheim J; Semaan A; Gevensleben H; Groening S; Knoblich A; Dietrich J; Weber J; Kalff JC; Bootz F; Kristiansen G; Dietrich D
    Br J Cancer; 2018 May; 118(9):1217-1228. PubMed ID: 29610456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved sensitivity of circulating tumor DNA measurement using short PCR amplicons.
    Andersen RF; Spindler KL; Brandslund I; Jakobsen A; Pallisgaard N
    Clin Chim Acta; 2015 Jan; 439():97-101. PubMed ID: 25446878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood circulating tumor DNA for non-invasive genotyping of colon cancer patients.
    Siravegna G; Bardelli A
    Mol Oncol; 2016 Mar; 10(3):475-80. PubMed ID: 26774880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of circulating serum DNA integrity in colorectal cancer patients.
    Yörüker EE; Özgür E; Keskin M; Dalay N; Holdenrieder S; Gezer U
    Anticancer Res; 2015 Apr; 35(4):2435-40. PubMed ID: 25862911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Plasma Tumor DNA.
    Parsons HA; Beaver JA; Park BH
    Adv Exp Med Biol; 2016; 882():259-76. PubMed ID: 26987539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.